Ovid Therapeutics Inc. (OVID) Social Stream

Ovid Therapeutics Inc. (OVID): $3.06

-0.04 (-1.29%)

POWR Rating

Component Grades













Add OVID to Watchlist
Sign Up

Industry: Biotech


of 459

in industry

Ovid Therapeutics Inc (OVID) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ovid Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 3 $7 $4 $5.5 $3.14 75.16%
2021-11-15 5 $7 $4 $5.5 $3.14 75.16%

The Trend in the Analyst Price Target

Over the past 135 days, OVID's average price target has gone up $0.62.

Over the past 42 weeks, OVID's average upside potential has been 54.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 7 7 4 4.88 3.74 30.48%
2021-02-06 3 8 4 6.00 3.19 88.09%
2021-07-03 7 7 4 4.88 4.04 20.79%
2021-08-28 5 7 4 4.75 3.52 34.94%
2021-02-27 3 8 4 6.00 2.95 103.39%

OVID Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations

Over the past 92 days, OVID's average broker recommendation rating improved by 0.3.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • OVID has a greater average analyst price target than 6.9% of all US stocks.
  • OVID has a higher number of analysts covering the stock than 42.76% of all US stocks.
  • In the context of stocks in the small market cap category, Ovid Therapeutics Inc's variance in analysts' estimates is lower than -48.42% of them.
  • In the context of Pharmaceutical Products stocks, Ovid Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 51.72% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Ovid Therapeutics Inc are OTIC, ORPH, and ORMP.

Is OVID a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.63 seconds.